There is life after diagnosis.
Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join The Patient Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
Recent Episodes
Empowering Lives: Advancements in Chronic Lymphocytic Leukemia
Join us as we sit down with Dr. Deborah Stephens from the University of Utah, as we discover the latest breakthroughs in treating chronic lymphocytic leukemia (CLL). We also gain valuable insights into enhancing patient’s quality of life In this episode, Dr. Stephens emphasizes the importance of effective communication with your healthcare team, unveiling strategies that not only optimize disease
Accelerating Hope for Aggressive Non-Hodgkin Lymphoma
Delve into the complex landscape of non-Hodgkin lymphoma research, where a cure is pursued amidst a backdrop of over 100 subtypes of this disease. In this episode, Dr. Kieron Dunleavy, of MedStar Georgetown University Hospital, breaks down the differences in treatments, prognosis and goals for both slow-growing and aggressive subtypes of non-Hodgkin lymphoma. Discover the remarkable momentum of scientific progress
Treating Rare Disease with Compassion: Chronic Myelomonocytic Leukemia (CMML)
While chronic myelomonocytic leukemia (CMML) is a rare disease, it is not rare to the patients and loved ones who are affected by it. In this episode, Dr. Mrinal Patnaik of the Mayo Clinic in Rochester, MN, discusses the unique aspects of CMML and how it is classified and treated. Dr. Patnaik shares the latest treatment advances and discusses the
The Bloodline Live: Emphasizing the Patient Voice in Young Adult Cancer Care
When adolescents and young adults (AYA) are diagnosed with cancer, they face unique challenges that aren’t seen as frequently in other age groups. Healthcare and nonprofit professionals around the world are listening to patients and researching these issues to improve quality of life during and after treatment. In this episode, we are taking you onsite to the 5th Annual Global Adolescent and
Be Informed: Beneficial Medicare Changes
Cancer related costs can be an overwhelming burden for patients on Medicare. However, new changes in Medicare will directly impact cancer patients and ease this financial burden. In this episode, Brian Connell, the Vice President of Federal Affairs at LLS, discusses the new changes in Medicare for 2024 and 2025, as a result of the recent Inflation Reduction Act. Medicare
Support for The Bloodline with LLS provided by AbbVie; BeiGene; Bristol Myers Squibb; Eli Lilly and Company; Genentech & Biogen; GSK; Janssen Oncology and Legend Biotech; Kite, A Gilead Company; Merck; Novartis; Pharmacyclics, an AbbVie company & Janssen Biotech; and Taiho Oncology.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.